講師介紹

< 回列表
陳璿宇
  • 中央研究院統計科學研究所研究員
Opening
角色 座長
日期時間 05/02 14:10 - 14:15
地點 701D
Beyond CD47 Blockade: Redefining the CD47-SIPRα Field for Next-Generation Innate Immunotherapy
角色 座長
日期時間 05/02 15:05 - 15:55
地點 701D
會員大會暨理監事改選投票、開票
角色 座長
日期時間 05/02 16:00 - 17:00
地點 701D
學歷 / 訓練
2007, PhD., Epidemiology, National Taiwan University, Taiwan
專業與研究經歷
2023 - Present, Research Fellow, Institute of Statistical Science, Academia Sinica
2016 - 2023, Associate Research Fellow, Institute of Statistical Science, Academia Sinica
2018 - 2019, Chief Scientist, Acer Inc., Taiwan
2017 - Present, Secretary-general, Taiwan Genomics and Genetics Society, Taiwan
重要出版品
  • Ya-Hsuan Chang, Tzu-Chan Hong, Kuen-Tyng Lin,…,Hsuan-Yu Chen*, Sung-Liang Yu, Ming-Shiang Wu, Yu-Ju Chen, Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer, Gut, doi: 10.1136/gutjnl-2025-337247
  • Shankha Satpathy, Natalie M. Clark, Yi-Ju Chen,…,Hsuan-Yu Chen*, Alexey I. Nesvizhskii, Steven A. Carr, D. R. Mani, Marcin P. Cieslik, Yu-Ju Chen, Michael A. Gillette, 2025, Integrative Analysis of Lung Adenocarcinoma Across Diverse Ethnicities and Exposures, Cancer Cell, 43: 1731-1757
  • Shih-Pin Chen, Ya-Hsuan Chang, Yen-Feng Wang, Hsuan-Yu Chen*, Shuu-Jiun Wang, 2025, Composite microRNA-genetic risk score model links to migraine and implicates its pathogenesis, Brain, 148: 2178-2188
  • Yi-Ju Chen, Theodoros I. Roumeliotis, Ya-Hsuan Chang,…,Hsuan-Yu Chen*, Pan-Chyr Yang, Yu-Ju Chen, 2020, Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression, Cell, 182, 226-244
  • Poyin Huang, Yuan-Han Yang, Ya-Hsuan Chang, Shu-Ling Chang, Mei-Chuan Chou, Chiou-Lian Lai, Ching-Kuan Liu, Hsuan-Yu Chen*, 2020, Association of early-onset Alzheimers disease with germline-generated high affinity self-antigen load, Translational Psychiatry, 10, 146.
  • Chen HY, Yu SL, Ho BC,…,Chang GC, Yang PC, Li KC, 2015, R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability., Journal of Clinical Oncology, 33, 2303-2310.
  • Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC, 2007, A five-gene signature and clinical outcome in non-small-cell lung cancer., New England Journal of Medicine, 356, 11-20.